menu search

Here's why cintas (ctas) is a strong growth stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Pre...

October 2, 2023, 11:16 am

Why royal philips (phg) is a top growth stock for the long-term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Pre...

October 2, 2023, 11:16 am

Investors heavily search vipshop holdings limited (vips): here is what you need to know

Zacks.com users have recently been watching Vipshop Holdings Limited (VIPS) quite a bit. Thus, it is worth knowing the facts that could determine the ...

October 2, 2023, 10:34 am

Investors heavily search delta air lines, inc. (dal): here is what you need to know

Delta (DAL) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock....

October 2, 2023, 10:33 am

Rheology modifiers market to reach usd 7586.1 million by 2023, predicts chemview consulting

Major rheology modifiers market players include, the Dow Chemical Company, BASF SE, Lubrizol Corporation, Arkema, Clariant, Croda International Plc., ...

October 2, 2023, 10:30 am

Eldorado gold’s potential guidance miss: weighing the risks and puri’s sell rating justification

Bank of America Securities analyst Harmen Puri reiterated a Sell rating on Eldorado Gold (EGO – Resea...

October 2, 2023, 10:14 am

Chelsea owners considering more borrowing to fund spending spree

Chelsea FC's owners are considering borrowing up to £250 million to help continue funding its spending...

October 2, 2023, 9:34 am

2 seasonal stocks to warm up your portfolio

With winter soon approaching comes the potential for more inclement weather. Storms and blistery temperatures will drive the demand for companies that...

October 2, 2023, 8:45 am

New iphones hot in a bad way, but apple stock chart is bullish

If you look at the tech stocks tracked by the Technology Select Sector SPDR Fund NYseaRCA: XLK, Apple i...

October 2, 2023, 8:07 am

Bank of america's stephen suttmeier lays out the techincal setup for q4

Stephen Suttmeier, Chief Equity Technical Strategist at Bank of America Merrill Lynch Global Research, ...

October 2, 2023, 7:06 am

U.s. fda declines to approve eli lilly's skin disease drug

The U.S. Food and Drug Administration has declined to approve Eli Lilly's drug to treat a type of skin disea...

October 2, 2023, 6:54 am

Why zscaler stock raced 3% higher on friday

An influential investment bank published a new research note on three cybersecurity stocks. Zscaler top...

October 2, 2023, 6:25 am

Arkw: an almost too obvious future

ARK Next Generation Internet ETF focuses on investing in pioneering technologies like cloud computing, blockchain, and AI. The fund is actively manage...

October 2, 2023, 6:15 am

Ifx expo international 2023 wraps up another successful event

The city welcomed over 4,000 fintech professionals from across the world for the event that was held at the City of Dreams Integrated Resort in Limass...

October 2, 2023, 6:04 am

Local retailers turn net buyers of equities last week, says midf

The top three sectors with net foreign inflows for the week were utilities, technology and property, says MIDF Re...

October 2, 2023, 5:44 am

Gallium oxide market accelerates at 44.1% cagr to reach us$ 46.5 million by 2033: fact.mr report

Gallium Oxide Suppliers Should Focus on Semiconductor Industry to Get Best Returns Rockville, Oct. 02, 2023 (GLOBE NEWSWIRE) — As per this latest re...

October 2, 2023, 5:22 am

Genentech to present new key clinical and real-world data at ectrims-actrims 2023 showcasing strength of long-term outcomes in ms and nmosd

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), will present new data for Ocrevus®...

October 2, 2023, 1:00 am

Roche to present new key clinical and real-world data at ectrims-actrims 2023 showcasing strength of long-term outcomes in ms and nmosd

Basel, 02 October 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) will present new data for OCREVUS® (ocrelizumab) and investigational Bruton's tyrosine ki...

October 2, 2023, 1:00 am

Zscaler: competitive position remains strong

Zscaler surpasses billing guidance in 4Q23 with a record influx of new opportunities and strong customer interest. ZS's robust expertise in cloud secu...

October 2, 2023, 12:31 am

Top marijuana stocks to watch as new month begins

People interested in legal cannabis are searching for ways to invest. This brings them to finding out a...

October 1, 2023, 4:04 pm


Search within

Pages Search Results: